Research Paper Volume 11, Issue 23 pp 10883—10901
Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer
Figure 7. Comparison of the expression of LM22 identified by CIBERSORT between high and low CD204 expression groups (A). Correlation of CD204 and immunosuppressive molecules among the luminal, HER2-positive, and basal-like subtypes of breast cancer (B).